title: Is conventional antiplatelet therapy for the prevention of coronary stent thrombosis always safe? A case report of a patient with polycythemia vera.
abstract: A 63-year-old male patient with both polycythemia vera and unstable angina underwent an angioplasty with the deployment of a stent. Conventional antiplatelet therapy failed to prevent stent thrombosis and an association with chronic anticoagulation seemed to be the only safe treatment. Moreover, after the late withdrawal of warfarin, stent thrombosis recurred.
authors.affiliation: Division of Interventional Cardiology, Istituto Clinico Humanitas, Rozzano (MI), Italy.
authors.forename: Dennis
authors.initials: D
authors.lastname: Zavalloni
authors.forename: Federica
authors.initials: F
authors.lastname: Marsico
authors.forename: Francesco
authors.initials: F
authors.lastname: Milone
authors.forename: Patrizia
authors.initials: P
authors.lastname: Presbitero
mesh_terms: D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D019917:Blood Vessel Prosthesis Implantation; D003131:Combined Modality Therapy; D017023:Coronary Angiography; D023921:Coronary Stenosis / Q000175:diagnosis / Q000628:therapy; D003328:Coronary Thrombosis / Q000175:diagnosis / Q000517:prevention & control*; D004452:Echocardiography; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011087:Polycythemia Vera / Q000175:diagnosis / Q000628:therapy*; D015607:Stents
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab